“I never set out to battle county government. I simply wanted to sell the food I grow—healthy, local produce and value-added goods—to my neighbors,” Georgia farmer Stephanie Jones shared with The Gateway Pundit. In an era when Americans are increasingly demanding transparency and control over what ends up on their plates, the farm-to-table movement has emerged as a powerful counter to our industrialized food system. Q: Stephanie, can you tell us about the current situation with your farm stand and the county? A: The county recently paused our operations, claiming that because we sell items from other local Georgia vendors, we are operating a ‘retail store’ rather than a farm stand. Because our land isn’t zoned for commercial retail, they required us to file for a Conditional Use Permit. We have complied and filed for the permit under that retail definition just to keep the process moving, but the reality is that a retail label completely misrepresents what we do. We are not a big-box store; we are a working family farm dedicated to community wellness and local food security. In fact, Georgia state law explicitly protects agritourism and farm stands, allowing us to sell value-added products that are grown, baked, or produced right here in Georgia without needing a retail license. ...we are hopeful the county will work with us to recognize the state-level protections designed for farms like ours. Q: What frustrates you most about the current food system? A: The disconnect is profound. If bread from a grocery store can sit on a counter for six weeks without molding, we have to question our food system. People are craving alternatives to the highly processed, dye-filled, and pesticide-heavy options on supermarket shelves... We need the freedom to choose where our food comes from and how it is grown. This is a popular movement across the nation. Recently, The Wellness Company announced a first of its kind human observational study of the off-label use of Ivermectin and Mebendazole in the treatment of cancer was published by the Anticancer Research Journal. Dr. Peter McCullough, Chief Scientific Officer for The Wellness Company, and one of the authors of the manuscript, praised the results of this groundbreaking analysis. “In this first of its kind human observational analysis, off-label use of Ivermectin+Mebendazole showed a remarkable 84% Clinical Benefit Ratio in the treatment of cancer. These results indicate that the inexpensive and safe off-label applications of these medications could be an important breakthrough in the treatment of cancer.” The report analyzed 197 cancer patients who were prescribed ivermectin and mebendazole off label. Participants received compounded oral capsules containing 25 mg of ivermectin and 250 mg of mebendazole. After 6-months, participants reported an 84% Clinical Benefit Ratio. With 48% of participants reporting regression or no evidence of cancer, while 36% reported disease stability. Only 15.6% of participants reported disease progression.
Fighting for Food Freedom: A Georgia Farmer’s Stand Against Bureaucratic Overreach:
ANTICANCER RESEARCH JOURNAL PUBLISHES GROUNDBREAKING IVERMECTIN STUDY:
Sponsored Content [which means they paid for this article to appear.]